Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.
Shares of the Israel-based cyber security firm rose more than 11% on Friday and are moving on heavy volume Monday as the situation in the Middle East develops. According to data from Benzinga Pro, more than 25.8 million shares have already been traded in the session, far exceeding the stock's 100-day average volume of 3.134 million shares.
Shares of Medical Properties Trust, Inc. (NYSE: MPW) rose sharply in today’s pre-market trading after the company announced that it sold its majority interest in Utah Hospitals.
Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter estimates and said it no longer expects to generate positive adjusted free
U.S. stocks traded higher this morning, with the Dow Jones index gaining over 50 points on Tuesday.
Following the market opening Tuesday, the Dow traded up 0.20% to 38,972.32 while the NASDAQ rose 0.40% to 16,319.23. The S&P 500 also rose, gaining, 0.32% to 5,219.29.
Shares of Agenus Inc. (NASDAQ: AGEN) fell sharply during Monday’s session.
Agenus disclosed a 1-for-20 reverse stock split of common stock.
Agenus Inc. (NASDAQ: AGEN) declined 17% to $0.4181 on Monday.
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Friday.
The Dow traded up 0.89% to 38,941.18 while the NASDAQ rose 1.26% to 16,251.98. The S&P 500 also rose, gaining, 1.10% to 5,203.90.